Chemed Financials

CXM Stock

EUR 358.00 12.00 3.47%

We suggest to use Chemed fundamental analysis to see if markets are presently undervaluing or overvaluing the company. Put another way, you can use it to find out if Chemed is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate thirty-six available fundamental indicators for Chemed, which can be compared to its peers. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Chemed to be traded at €429.6 in 90 days.

Covid

Interest Hikes

Chemed Balance Sheet Chart

At this time, Chemed's Long Term Debt is most likely to decrease significantly in the upcoming years. The Chemed's current Inventory is estimated to increase to about 8.4 M, while Other Current Liabilities is projected to decrease to roughly 42.1 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Key indicators impacting Chemed's financial strength include:

Current Value

Last Year

Change From Last Year

10 Year Trend

Operating Income

309.9 M

341.2 M

Moderately Down

Slightly volatile

Understanding current and past Chemed Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Chemed's financial statements are interrelated, with each one affecting the others. For example, an increase in Chemed's assets may result in an increase in income on the income statement.

Chemed Stock Summary

Chemed competes with Berkshire Hathaway, Chocoladefabriken, Seaboard, NVR, and WHITE MTNS. Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio. CHEMED CORP operates under Medical Care classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15707 people.

Foreign Associate	USA
Specialization	Health Care, Health Care Equipment & Services
Instrument	Germany Stock View All
Exchange	Frankfurt Exchange
ISIN	US16359R1032
Business Address	255 East Fifth
Sector	Health Care Providers & Services
Industry	Health Care
Benchmark	Dow Jones Industrial
Website	www.chemed.com
Phone	513 762 6690
Currency	EUR - Euro

You should never invest in Chemed without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Chemed Stock, because this is throwing your money away. Analyzing the key information contained in Chemed's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Chemed Key Financial Ratios

There are many critical financial ratios that Chemed's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Chemed reports annually and quarterly.

	Revenue	2.53 B
	Gross Profit	823.18 M
	EBITDA	404.4 M
	Net Income	265.24 M
	Total Asset	1.54 B

More Fundamentals

Chemed Key Balance Sheet Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	1.3B	1.4B	1.7B	1.7B	1.5B	1.4B
Other Current Liab	39.1M	61.0M	36.3M	42.7M	58.9M	42.1M
Other Liab	102.8M	135.4M	131.4M	143.1M	164.5M	118.7M
Net Tangible Assets	13.3M	147.9M	(72.4M)	108.8M	125.1M	131.4M
Retained Earnings	2.0B	2.2B	2.4B	2.7B	3.0B	1.9B
Accounts Payable	73.0M	41.9M	48.3M	44.1M	64.5M	55.5M
Cash	32.9M	74.1M	264.0M	178.4M	74.5M	78.2M
Other Assets	86.5M	97.6M	107.0M	153.0M	176.0M	93.3M
Net Receivables	137.2M	139.4M	181.5M	171.2M	182.6M	153.9M
Good Will	578.6M	581.3M	585.0M	666.7M	667.0M	608.1M
Inventory	10.1M	10.3M	12.0M	8.2M	7.5M	8.4M
Other Current Assets	10.1M	6.6M	17.4M	18.5M	21.3M	15.4M
Total Liab	719.5M	643.3M	560.2M	549.6M	558.8M	547.6M
Total Current Assets	230.3M	272.6M	500.8M	394.7M	302.6M	279.8M
Intangible Assets	108.1M	99.7M	90.3M	92.2M	82.8M	94.0M
Common Stock	35.8M	36.3M	36.5M	36.8M	42.3M	38.7M
Net Invested Capital	808.3M	896.2M	1.1B	1.1B	979.4M	973.7M
Net Working Capital	(72.1M)	(24.6M)	188.8M	109.1M	15.5M	15.4M
Capital Stock	36.5M	36.8M	37.2M	37.4M	37.6M	40.3M

Chemed Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.

	2021	2022	2023	2024	2025	2026 (projected)
Interest Expense	1.9M	4.6M	3.1M	1.8M	1.8M	2.3M
Total Revenue	2.1B	2.1B	2.3B	2.4B	2.5B	2.2B
Gross Profit	769.8M	765.1M	798.8M	854.3M	823.2M	709.4M
Operating Income	343.0M	343.5M	342.8M	366.9M	341.2M	309.9M
Ebit	266.5M	314.6M	344.0M	347.2M	399.3M	281.3M
Cost Of Revenue	1.4B	1.4B	1.5B	1.6B	1.7B	1.4B
Income Before Tax	350.3M	329.7M	350.4M	399.5M	355.8M	304.3M
Net Income	268.6M	249.6M	272.5M	302.0M	265.2M	230.9M
Income Tax Expense	41.7M	76.5M	81.8M	80.1M	92.1M	65.3M
Tax Provision	81.8M	80.1M	77.9M	97.5M	90.5M	73.4M
Net Interest Income	(1.5M)	(4.2M)	3.2M	12.8M	7.0M	7.3M
Interest Income	377K	355K	6.3M	14.6M	8.7M	9.2M
Ebitda	311.3M	454.9M	411.2M	393.4M	452.5M	368.7M

Chemed Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Chemed. It measures of how well Chemed is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Chemed brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Chemed had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Chemed has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (capital allocation) and investing in non-business activities like paying off debt or making acquisitions.

	2021	2022	2023	2024	2025	2026 (projected)
Change To Inventory	(3.0M)	(162K)	(1.7M)	3.8M	650K	682.5K
Change In Cash	(129.8M)	41.2M	189.8M	(85.6M)	(103.8M)	(98.6M)
Net Borrowings	196.9M	(99.4M)	(81.8M)	(15.7M)	11.0M	11.5M
Depreciation	53.3M	53.7M	60.9M	63.0M	64.8M	49.7M
Dividends Paid	22.0M	22.0M	23.5M	27.1M	31.7M	22.9M
Capital Expenditures	58.7M	57.3M	56.9M	49.5M	62.8M	58.8M
Net Income	268.6M	249.6M	272.5M	302.0M	265.2M	230.9M
Change To Netincome	28.2M	68.5M	7.5M	34.2M	39.4M	33.2M
Investments	(57.8M)	(59.4M)	(60.6M)	(143.9M)	(129.5M)	(136.0M)
End Period Cash Flow	32.9M	74.1M	264.0M	178.4M	74.5M	90.6M
Free Cash Flow	249.9M	252.6M	273.4M	368.0M	325.5M	303.2M
Other Non Cash Items	(7.8M)	4.3M	3.5M	(3.7M)	2.2M	1.2M

Chemed Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Chemed's current stock value. Our valuation model uses many indicators to compare Chemed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chemed competition to find correlations between indicators driving Chemed's intrinsic value. More Info.

Chemed is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Chemed is roughly 1.89 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chemed's earnings, one of the primary drivers of an investment's value.

Chemed Total Assets Over Time

Most indicators from Chemed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chemed current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

The current Selling General Administrative is estimated to decrease to about 352.2 M. The current Tax Provision is estimated to decrease to about 73.4 M

	2023	2024	2025	2026 (projected)
Gross Profit	798.8M	854.3M	823.2M	709.4M
Total Revenue	2.3B	2.4B	2.5B	2.2B

Gross Profit Total Revenue

Chemed fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Good Will	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Non Current Assets Total
Total Assets		0.78	0.96	0.96	0.94	0.83	0.96	0.38	0.81	0.93	-0.1	0.85	0.95	0.8	0.05	-0.44	0.82	-0.87	0.95	0.56	0.89	0.76	0.73	0.79	0.96	0.98
Other Current Liab	0.78		0.81	0.68	0.85	0.7	0.77	0.4	0.44	0.79	0.09	0.59	0.8	0.56	0.06	-0.47	0.78	-0.75	0.81	0.21	0.53	0.58	0.74	0.75	0.82	0.83
Total Current Liabilities	0.96	0.81		0.87	0.91	0.77	0.9	0.51	0.72	0.86	0.05	0.73	0.9	0.84	0.03	-0.44	0.91	-0.89	0.95	0.37	0.81	0.76	0.83	0.76	0.95	0.97
Total Stockholder Equity	0.96	0.68	0.87		0.88	0.89	0.93	0.22	0.87	0.9	-0.24	0.85	0.91	0.69	0.02	-0.37	0.64	-0.81	0.88	0.68	0.92	0.75	0.61	0.77	0.88	0.92
Other Liab	0.94	0.85	0.91	0.88		0.78	0.97	0.49	0.71	0.96	0.0	0.8	0.91	0.73	0.18	-0.49	0.81	-0.81	0.97	0.56	0.81	0.75	0.62	0.86	0.94	0.93
Net Tangible Assets	0.83	0.7	0.77	0.89	0.78		0.8	0.12	0.73	0.77	-0.3	0.65	0.81	0.5	-0.1	-0.41	0.5	-0.76	0.76	0.53	0.75	0.76	0.53	0.78	0.75	0.82
Retained Earnings	0.96	0.77	0.9	0.93	0.97	0.8		0.42	0.72	0.98	-0.18	0.87	0.96	0.73	0.15	-0.49	0.78	-0.83	0.97	0.67	0.82	0.8	0.58	0.88	0.96	0.95
Accounts Payable	0.38	0.4	0.51	0.22	0.49	0.12	0.42		0.05	0.32	0.48	0.3	0.47	0.32	0.15	-0.54	0.61	-0.48	0.52	0.1	0.16	0.42	0.46	0.57	0.48	0.45
Cash	0.81	0.44	0.72	0.87	0.71	0.73	0.72	0.05		0.71	-0.05	0.71	0.64	0.7	0.02	-0.19	0.48	-0.56	0.66	0.59	0.98	0.45	0.44	0.45	0.64	0.69
Other Assets	0.93	0.79	0.86	0.9	0.96	0.77	0.98	0.32	0.71		-0.24	0.86	0.9	0.75	0.21	-0.42	0.75	-0.77	0.95	0.66	0.81	0.75	0.52	0.83	0.94	0.9
Long Term Debt	-0.1	0.09	0.05	-0.24	0.0	-0.3	-0.18	0.48	-0.05	-0.24		-0.22	-0.13	-0.02	-0.06	-0.06	0.23	0.11	-0.07	-0.41	-0.09	-0.32	0.21	-0.17	-0.13	-0.08
Net Receivables	0.85	0.59	0.73	0.85	0.8	0.65	0.87	0.3	0.71	0.86	-0.22		0.84	0.67	0.16	-0.5	0.61	-0.64	0.78	0.79	0.82	0.56	0.43	0.77	0.8	0.81
Good Will	0.95	0.8	0.9	0.91	0.91	0.81	0.96	0.47	0.64	0.9	-0.13	0.84		0.64	0.04	-0.55	0.78	-0.88	0.93	0.58	0.75	0.78	0.71	0.89	0.94	0.98
Inventory	0.8	0.56	0.84	0.69	0.73	0.5	0.73	0.32	0.7	0.75	-0.02	0.67	0.64		0.11	-0.34	0.84	-0.68	0.75	0.31	0.77	0.47	0.62	0.51	0.78	0.76
Other Current Assets	0.05	0.06	0.03	0.02	0.18	-0.1	0.15	0.15	0.02	0.21	-0.06	0.16	0.04	0.11		-0.5	0.12	0.19	0.11	0.35	0.11	-0.02	-0.24	0.11	0.08	0.03
Other Stockholder Equity	-0.44	-0.47	-0.44	-0.37	-0.49	-0.41	-0.49	-0.54	-0.19	-0.42	-0.06	-0.5	-0.55	-0.34	-0.5		-0.47	0.37	-0.42	-0.4	-0.32	-0.27	-0.25	-0.67	-0.4	-0.51
Total Liab	0.82	0.78	0.91	0.64	0.81	0.5	0.78	0.61	0.48	0.75	0.23	0.61	0.78	0.84	0.12	-0.47		-0.78	0.86	0.16	0.6	0.59	0.82	0.64	0.87	0.87
Deferred Long Term Liab	-0.87	-0.75	-0.89	-0.81	-0.81	-0.76	-0.83	-0.48	-0.56	-0.77	0.11	-0.64	-0.88	-0.68	0.19	0.37	-0.78		-0.87	-0.26	-0.64	-0.82	-0.8	-0.76	-0.88	-0.91
Long Term Investments	0.95	0.81	0.95	0.88	0.97	0.76	0.97	0.52	0.66	0.95	-0.07	0.78	0.93	0.75	0.11	-0.42	0.86	-0.87		0.52	0.76	0.85	0.69	0.85	0.99	0.95
Short Long Term Debt	0.56	0.21	0.37	0.68	0.56	0.53	0.67	0.1	0.59	0.66	-0.41	0.79	0.58	0.31	0.35	-0.4	0.16	-0.26	0.52		0.66	0.44	-0.06	0.63	0.5	0.48
Total Current Assets	0.89	0.53	0.81	0.92	0.81	0.75	0.82	0.16	0.98	0.81	-0.09	0.82	0.75	0.77	0.11	-0.32	0.6	-0.64	0.76	0.66		0.53	0.49	0.58	0.75	0.79
Short Term Debt	0.76	0.58	0.76	0.75	0.75	0.76	0.8	0.42	0.45	0.75	-0.32	0.56	0.78	0.47	-0.02	-0.27	0.59	-0.82	0.85	0.44	0.53		0.54	0.79	0.83	0.78
Intangible Assets	0.73	0.74	0.83	0.61	0.62	0.53	0.58	0.46	0.44	0.52	0.21	0.43	0.71	0.62	-0.24	-0.25	0.82	-0.8	0.69	-0.06	0.49	0.54		0.49	0.75	0.79
Common Stock	0.79	0.75	0.76	0.77	0.86	0.78	0.88	0.57	0.45	0.83	-0.17	0.77	0.89	0.51	0.11	-0.67	0.64	-0.76	0.85	0.63	0.58	0.79	0.49		0.83	0.84
Property Plant Equipment	0.96	0.82	0.95	0.88	0.94	0.75	0.96	0.48	0.64	0.94	-0.13	0.8	0.94	0.78	0.08	-0.4	0.87	-0.88	0.99	0.5	0.75	0.83	0.75	0.83		0.97
Non Current Assets Total	0.98	0.83	0.97	0.92	0.93	0.82	0.95	0.45	0.69	0.9	-0.08	0.81	0.98	0.76	0.03	-0.51	0.87	-0.91	0.95	0.48	0.79	0.78	0.79	0.84	0.97

Click cells to compare fundamentals

Chemed Account Relationship Matchups

Chemed fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	1.3B	1.4B	1.7B	1.7B	1.5B	1.4B
Other Current Liab	39.1M	61.0M	36.3M	42.7M	58.9M	42.1M
Other Liab	102.8M	135.4M	131.4M	143.1M	164.5M	118.7M
Net Tangible Assets	13.3M	147.9M	(72.4M)	108.8M	125.1M	131.4M
Retained Earnings	2.0B	2.2B	2.4B	2.7B	3.0B	1.9B
Accounts Payable	73.0M	41.9M	48.3M	44.1M	64.5M	55.5M
Cash	32.9M	74.1M	264.0M	178.4M	74.5M	78.2M
Other Assets	86.5M	97.6M	107.0M	153.0M	176.0M	93.3M
Net Receivables	137.2M	139.4M	181.5M	171.2M	182.6M	153.9M
Good Will	578.6M	581.3M	585.0M	666.7M	667.0M	608.1M
Inventory	10.1M	10.3M	12.0M	8.2M	7.5M	8.4M
Other Current Assets	10.1M	6.6M	17.4M	18.5M	21.3M	15.4M
Total Liab	719.5M	643.3M	560.2M	549.6M	558.8M	547.6M
Total Current Assets	230.3M	272.6M	500.8M	394.7M	302.6M	279.8M
Intangible Assets	108.1M	99.7M	90.3M	92.2M	82.8M	94.0M
Common Stock	35.8M	36.3M	36.5M	36.8M	42.3M	38.7M
Net Invested Capital	808.3M	896.2M	1.1B	1.1B	979.4M	973.7M
Net Working Capital	(72.1M)	(24.6M)	188.8M	109.1M	15.5M	15.4M
Capital Stock	36.5M	36.8M	37.2M	37.4M	37.6M	40.3M

Chemed March 4, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Chemed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Chemed. We use our internally-developed statistical techniques to arrive at the intrinsic value of Chemed based on widely used predictive technical indicators. In general, we focus on analyzing Chemed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Chemed's daily price indicators and compare them against related drivers.

	Information Ratio	(0.03)
	Maximum Drawdown	16.91
	Value At Risk	(2.63)
	Potential Upside	2.81

Complementary Tools for Chemed Stock analysis

When running Chemed's price analysis, check to measure Chemed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemed is operating at the current time. Most of Chemed's value examination focuses on studying past and present price action to predict the probability of Chemed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemed's price. Additionally, you may evaluate how the addition of Chemed to your portfolios can decrease your overall portfolio volatility.

	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC